Withdrawal of dopamine agonist treatment in patients with hyperprolactinaemia: A systematic review and meta-analysis.
Clin Endocrinol (Oxf)
; 97(5): 519-531, 2022 Nov.
Article
in En
| MEDLINE
| ID: mdl-35261059
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pituitary Neoplasms
/
Hyperprolactinemia
/
Prolactinoma
Type of study:
Observational_studies
/
Prognostic_studies
/
Systematic_reviews
Limits:
Humans
Language:
En
Journal:
Clin Endocrinol (Oxf)
Year:
2022
Document type:
Article
Affiliation country:
Denmark
Country of publication:
United kingdom